Vancomycin is commonly added as empiric therapy for febrile neutropenia. A retrospective chart review was conducted at a large community teaching institution to evaluate vancomycin use in oncology patients. The results revealed that a majority of empiric vancomycin therapy was inappropriate, raising concern for antibiotic resistance and prompting opportunities for improvement.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324182 | PMC |
| http://dx.doi.org/10.1093/ofid/ofu006 | DOI Listing |
Publication Analysis
Top Keywords
empiric vancomycin
8
oncology patients
8
vancomycin febrile
4
febrile neutropenic
4
neutropenic oncology
4
patients vancomycin
4
vancomycin commonly
4
commonly empiric
4
empiric therapy
4
therapy febrile
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!